HLA compatibility is considered the key criterion for selecting donors for allo-HSCT. DKMS study data presented at the DGHO ...
In this interview, Dr. Anderson discusses the advantages of dd-cfDNA as a transplant monitoring tool and the regulatory and ...
Cellular therapies, including TIL, TCR, and CAR-T, are transforming lung cancer care by utilizing personalized immune cells ...
Tecelra is the first engineered cell therapy for the treatment of certain patients with advanced synovial sarcoma. One year ...
A sign on U.S. 41 in Newton County guides curious travelers to a “Bison Viewing Area,” the most well-known spot in the ...
People with blood type A may be at higher risk of developing autoimmune liver disease, resulting in potentially ...
The increasing integration of genomic medicine into routine medical care brings to light issues of complexity and uncertainty ...
Pluristyx's platform technology was developed specifically to overcome this challenge. This Breakthrough T1D collaboration will fund the use of precise gene editing to engineer Pluristyx's exclusively ...
Detailed price information for Tevogen Bio Holdings Inc (TVGN-Q) from The Globe and Mail including charting and trades.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback